Page 54 - Ip Group News Today

A University of Queensland startup company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of

Investegate announcements from IP Group PLC, Transaction in Own Shares

Crescendo Biologics Ltd (Crescendo), a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, today announces a new translational science collaboration with

Weeds beware! Microwave technology is about to zap them out of existence as an Aussie start-up attracts international attention.

A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP Group, a UK-based intellectual property business.

A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of

Investegate announcements from IP Group PLC, Transaction in Own Shares

Oxford BioMedica licences technology for cystic fibrosis treatment | Financial News

BioPharma

Investegate announcements from IP Group PLC, Transaction in Own Shares